Cannabis Corner: These stocks are all poised for gains

Article Excerpt

First, the good news: widening cannabis legalization will eventually lead to some great business successes. The bad news is that only a few of the multitude of cannabis stocks today will pay off for investors. Consumer cannabis demand is high, but growing and distributing it across multiple markets is more difficult. With “Cannabis Corner,” we focus on quality stocks that are most likely to emerge as winners in the “Wild West” of marijuana investing. VALENS CO. $0.87 (Toronto symbol VLNS; TSINetwork Rating: Speculative) (www.valenscompany.com; Shares o/s: 80.1 million; Market cap: $64.1 million; TSI Cannabis Quality Rating [CQR]: ) has launched two new brands, Versus and Contraband. These are designed to meet the needs of target consumers in the value and premium markets, respectively. The Versus launch follows Valens’ acquisition of value-brand Verse Cannabis in September 2021. The Contraband launch follows the acquisition of Citizen Stash and leverages its catalogue of premium genetically enhanced cannabis and expands Valens’ reach to that fast-growing segment. Valens is an aggressive buy. VILLAGE…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.